The tumor microenvironment is the surrounding tissue, blood vessels, immune cells, and signaling molecules that a cancer lives within and interacts with. It is not just the tumor cells themselves but the whole neighborhood that can either fight the cancer or, more often, help it grow, spread, and resist treatment. In mesothelioma, this environment includes chronic inflammation that asbestos fibers helped create.
Origin
The idea that cancer depends on its surroundings traces back to Stephen Paget's 1889 "seed and soil" hypothesis, but the modern term became central to cancer biology in the late 20th and early 21st centuries as researchers mapped the roles of immune and stromal cells.
Significance in Asbestos Context
For mesothelioma patients, the tumor microenvironment helps explain both how the disease develops and why it can be hard to treat. Asbestos fibers lodged in the lining of the lungs or abdomen drive decades of inflammation, and that inflamed, immune-suppressed environment is where the cancer eventually takes hold. It also matters for treatment, because immunotherapy works by trying to reprogram the immune cells in this environment to attack the tumor. Ask your oncologist whether your tumor's microenvironment features, such as immune markers, affect your eligibility for immunotherapy or clinical trials.
Example Sentence
The oncologist explained that mesothelioma's immune-suppressed tumor microenvironment was one reason the team was considering an immunotherapy combination.
Related Terms
Chronic Inflammation, Mesothelioma, Immunotherapy, Fibrosis, Angiogenesis, PD-L1
Notes
- Ask whether your tumor has been tested for immune markers like PD-L1 that relate to the microenvironment and may guide treatment.
- Discuss immunotherapy and clinical trial options, since several target the interaction between the tumor and its surrounding immune cells.
- Keep copies of pathology and molecular testing reports, which describe features of the microenvironment relevant to both care and any claim.
In the research library
195 studies in our medical research library mention Tumor Microenvironment in the title or abstract. Among the most cited:
- The Impact of Mesothelin in the Ovarian Cancer Tumor MicroenvironmentT.S. Hilliard, 2018 · Cancers · cited 54 times
- Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivoC. Li, V. Rezov, E. Joensuu, et al, 2018 · Scientific Reports · cited 40 times
- Single-Cell View of Tumor Microenvironment Gradients in Pleural MesotheliomaB. Giotti, K. Dolasia, W. Zhao, et al, 2024 · Cancer Discovery · cited 35 times
- ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironmentS. Ponce, S. Cedrés, C. Ricordel, et al, 2023 · Journal for Immunotherapy of Cancer · cited 34 times
- Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesotheliomaM. de Perrot, L. Wu, M. Cabanero, et al, 2020 · The Journal of Thoracic and Cardiovascular Surgery · cited 25 times
The journals that publish most on it: Cancers (18), Frontiers in Oncology (12), International Journal of Molecular Sciences (8).
Category: Biological & Molecular Mechanisms · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.